Though they may seem like equally vile presidential options, Bill Maher said on Real Time on Friday, there are differences between the two Republican presidential candidates.
“Donald Trump wants to build a wall to keep out creepy foreigners,” Maher explained. “Ted Cruz is proof we need it.”
Both conservatives and liberals, Maher said, have come to him asking for help deciding between the two.
“Republicans, I feel your pain,” he said. “You’re stuck between a rock and a gross place. The House of A*shole or the House of Douchebag. Team Werewolf or Team Vampire. Verizon or AT&T. But we have to accept that being a grown-up means hard choices between disgusting options.”
Having to make such a choice — which made him swig bleach at one point — had Maher comparing it to picking between the Zika and Ebola viruses.
He compared Trump to Ebola in this scenario, saying, “he’ll violently kill you right away.” Cruz, on the other hand, is like Zika because “we don’t see the damage until future generations.”
But in the end, Maher made the decision as to which Republican he feels is more awful — which can be seen below.
Democrats and Never-Trumpers gaming out ‘doomsday scenarios’ if president refuses to leave office: report
According to a report in the New York Times, Democratic strategists and Never-Trumper conservatives fear Donald Trump will refuse to leave office should he lose in November and are making plans and figuring out their legal options should such an unprecedented state of affairs come to pass.
The report, by the Times' Reid Epstein, begins with one such possible scenario.
‘Retaliation plain and simple’: Vaccine agency top Doc fired by Trump administration files whistleblower complaint
Dr. Rick Bright has retained an attorney and will be filing a whistleblower complaint after the Trump administration fired him from his position as head of the federal agency charged with developing a COVID-19 vaccine. Dr. Bright was moved to a different agency with a narrower focus after he raised concerns over President Donald Trump's obsession with promoting hydroxychloroquine, a malaria drug recent studies found doubles the death rate in coronavirus patients.
Checking blood for coronavirus antibodies – 3 questions answered about serological tests and immunity
Coronavirus testing in the United States is moving into a new phase as scientists begin looking into people’s blood for signs they’ve been infected by SARS-CoV-2, the virus that causes COVID-19. This technique is called serological testing.
Virologist Daniel Stadlbauer helped develop a serological test to detect SARS-CoV-2 antibodies and helped transfer it from the research lab to the clinical setting. Epidemiologist Aubree Gordon regularly uses serological assays in her research studies on influenza and dengue fever. She’s now established serological testing for SARS-CoV-2 in her research lab.